melanotan 2 with trt II (MT-II) Peptide Therapy Melanotan II - Wikipedia

What Exacerbates Risk in MTHFR Variants

The mean age of the study patients was found to be 32.90 7.92 years which was similar to the studies by Kumar et al .,[] Garg et al .,[] and Achar and Rathi.[] The disease duration of melasma in majority of patients (56.0%) was between 1 to 3 years, which is in concordance with the study by Kumar et al .[] Similar to the study by Khurana et al ., majority of patients (78%) in our study were found to be of Fitzpatrick skin type IV, followed by Fitzpatrick skin type V and type III.[] The assessment of mean difference in VAS over both cheeks before and after TA (right cheek) and glutathione (left cheek) revealed that both the treatment options were effective [Table 2]

The other is your individual mix of risk factors, like smoking, sleep apnea, or chronic obstructive pulmonary disease (COPD), that add to your risk of a dangerous clot, says Calvert

I feel better as I am now finding others who had the similar reactions